COVID-19 Update:

In this uncertain environment as a result of the global spread of the coronavirus COVID-19, I wanted to reassure you that our team at Stallergenes Greer remains fully committed to taking care of each other, our partners and our customers. We are quickly adapting to this rapidly evolving situation, implementing a variety of safety measures and supporting the allergy community in any way we can.

The industry within which Stallergenes Greer operates has been deemed essential by U.S. Department of Homeland Security. Our allergy immunotherapy products are vital to the health and safety of our global community, especially in this time of national emergency. As a result, we have continued to operate throughout the crisis and have product available to ship to physicians for use with their patients. Our Customer Service team is also on hand who can answer questions and address concerns.

Ensuring the health and safety of the people who manufacture our products and service our customers is our top priority. We are following all guidelines from the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC) and county health departments.

In addition to implementing global travel and meeting restrictions, we have flexible work arrangements in place for employees who can work from home, equipped our essential manufacturing staff with additional safety protocols, applied social distancing guidelines and increased cleaning and sanitization of all Stallergenes Greer facilities and offices as precautionary measures.

While I am pleased that our business practices have thus far prepared us for the challenges we are confronting, we will continue to quickly respond to this everchanging situation, and remain committed to supporting our people, our customers and our partners during this unprecedented time. If you have questions or concerns, please contact a member of our customer service team at 800.378.3906.

Best Regards,

Tibor Nemes

Head of Stallergenes Greer Americas